Fig. 7.
(A) Radiant efficiency at breast tumor over time of Cy5.5-labeled HPMA-CHP, HPMA-SCHP, and CHP administered to breast tumor-bearing mice over 168 h, and (B) comparison of breast tumor accumulation at timepoints t = 6, 12, 24, 48, 72, and 168 h, areas under the curve (AUC), and half-lives. (Mean ± SD, N = 5, *p < 0.05, **p < 0.01, ***p < 0.001).